MediMix
@Medi_Mix
MediMix, your communication partner with a focus on quality information in easy consumable formats, tailor-made for medical specialists.
ID:1642561920950575105
https://oncology.medimix.be/ 02-04-2023 16:17:55
430 Tweets
100 Followers
111 Following
๐ฅ๐ฒ๐๐ถ๐๐ฒ๐ ๐น๐ฒ๐ ๐บ๐ผ๐บ๐ฒ๐ป๐๐ ๐บ๐ฎ๐ฟ๐พ๐๐ฎ๐ป๐๐ ๐ฑ๐ ๐๐๐๐ข๐ ๐ฎ๐ฌ๐ฎ๐ฐ ๐ฎ๐๐ฒ๐ฐ ๐ ๐ฒ๐ฑ๐ถ๐บ๐ถ๐ ! ๐ Le professeur Van Laethem discute des รฉtudes PACHA-01 PRODIGE 43, FRESCO-2, GRECCAR 12, GASTFOX-PRODIGE 51 et MAZEPPA. Accรฉdez aux rรฉsumรฉs et vidรฉos ici :
๐ ๐ก๐ฒ๐ ๐บ๐ผ๐ฑ๐๐น๐ฒ ๐ผ๐ป ๐๐๐๐ ๐ถ๐ป ๐๐๐ป๐ด ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐ฎ๐๐ฎ๐ถ๐น๐ฎ๐ฏ๐น๐ฒ ๐ป๐ผ๐ ๐ผ๐ป ๐๐ฐ๐ฐ๐ฟ๐ฒ๐ฑ๐ถ๐ ๐ถ๐ ! ๐ Learn from experts Prof Dr Johan Vansteenkiste, Prof Dr Mariana Brandao and Prof Ingel Demedts. Access the latest insights, clinical trial results and more.
๐ Explore the latest on ADCs in #LungCancer ! Our 2nd module is now live on #AccrediMix .
๐ Register or login at accredimix.be and dive deeper into targeted therapy with insights from experts.
With the educational support of Daiichi Sankyo and AstraZeneca
*This
Real-world data on niraparib in first-line maintenance therapy for ovarian cancer, presented by Prof Toon Van Gorp from the University of Leuven, Belgium, at the SGO2024 congress in San Diego.
#MediMix #ovariancancer #SGO2024 #niraparib